Investigation on the Management for Patients with Echinococcosis Treated with Albendazole-Three PLADs,China,2019  

作　　者：Min Qin Liying Wang Ying Wang Xu Wang Jiaxi Lei Xixi Cheng Yu Feng Yanyan Hou Qian Wang Chuizhao Xue Laurent Gavotte Roger Frutos 

机构地区：[1]National Institute of Parasitic Diseases,Chinese Center for Disease Control and Prevention(Chinese Center for Tropical Diseases Research),NHC Key Laboratory of Parasite and Vector Biology,WHO Collaborating Centre for Tropical Diseases,National Center for International Research on Tropical Diseases,Shanghai,China [2]Espace-Dev,UMR 228,Universitéde Montpellier,Montpellier,France [3]Cirad,UMR 17,Intertryp,Campus international de Baillarguet,Montpellier,France [4]Gansu Provincial Center for Disease Control and Prevention,Lanzhou City,Gansu Province,China [5]Xinjiang Uygur Autonomous Region Center for Disease Control and Prevention,Urumqi City,Xinjiang Uygur Autonomous Region,China [6]Sichuan Provincial Center for Disease Control and Prevention,Chengdu City,Sichuan Province,China

出　　处：《China CDC weekly》2023年第20期437-441,共5页中国疾病预防控制中心周报（英文）

基　　金：The National Natural Science Foundation of China(Grant No.81703281);NHC Key Laboratory of Echinococcosis Prevention and Control,China(No.2021WZK1006).

摘　　要：Summary What is already known about this topic?In China,patients with echinococcosis receive complimentary healthcare services,such as medical treatment,diagnostic examinations,and follow-up care.Despite this,no studies have been conducted to assess the quality of patient management to date.What is added by this report?This study reviewed the medical records of 899 patients who underwent albendazole treatment across 10 endemic counties.Out of 634 evaluable patient files,the proportion of patients with a ratio of actual followup and reexamination times to theoretical follow-up and reexamination times≥0.8 were both low(21.92%and 23.19%,respectively).What are the implications for public health practices?This study identified weaknesses and specific issues in patient management and proposed feasible recommendations to enhance patient file documentation,follow-up,and reexamination.

关 键 词：TREATMENT SPITE feasible 

分 类 号：R532.32[医药卫生—内科学]